https://scholars.lib.ntu.edu.tw/handle/123456789/473466
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Su M.-C. | en_US |
dc.contributor.author | HUANG-CHUN LIEN | en_US |
dc.contributor.author | YUNG-MING JENG | en_US |
dc.creator | Su M.-C.;Lien H.-C.;Yung-Ming Jeng | - |
dc.date.accessioned | 2020-03-06T08:25:33Z | - |
dc.date.available | 2020-03-06T08:25:33Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-19444379632&doi=10.1016%2fj.canlet.2004.10.010&partnerID=40&md5=3e718ed6bb4bdd705302264000a29db9 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/473466 | - |
dc.description.abstract | The epidermal growth factor receptor (EGFR) is overexpressed in many epithelial tumors and plays an important role in the tumorigenesis of these tumors. Inhibitors of EGFR reduce the proliferation rate of cancers and are promising therapeutic agents of cancers. Recently, two studies have identified somatic mutations in the exons 18-21 of EGFR that were strongly correlated with robust clinical response to gefitinib treatment in patients with non-small cell lung cancer. To investigate whether EGFR mutation is involved in the tumorigenesis of hepatocellular carcinoma (HCC), we performed direct sequencing of exons 18-21 on 89 HCCs. No mutations causing amino acid changes or deletions were identified. The results indicate mutation of the kinase domain of EGFR does not play a significant role in the tumorigenesis of HCC and gefitinib is unlikely to be used as single-drug therapy for HCC. ? 2004 Elsevier Ireland Ltd. All rights reserved. | - |
dc.relation.ispartof | Cancer Letters | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | epidermal growth factor receptor; amino acid sequence; article; carcinogenesis; controlled study; exon; gene deletion; gene expression; gene mutation; gene sequence; human; human tissue; liver cell carcinoma; priority journal; sequence analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Base Sequence; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; DNA Mutational Analysis; DNA, Neoplasm; Exons; Female; Humans; Liver Neoplasms; Male; Middle Aged; Molecular Sequence Data; Point Mutation; Quinazolines; Receptor, Epidermal Growth Factor; Sequence Analysis, DNA | - |
dc.title | Absence of epidermal growth factor receptor exon 18-21 mutation in hepatocellular carcinoma | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.canlet.2004.10.010 | - |
dc.identifier.pmid | 15911107 | - |
dc.identifier.scopus | 2-s2.0-19444379632 | - |
dc.relation.pages | 117-121 | - |
dc.relation.journalvolume | 224 | - |
dc.relation.journalissue | 1 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Pathology | - |
crisitem.author.dept | Pathology-NTUH | - |
crisitem.author.dept | Pathology | - |
crisitem.author.dept | Pathology-NTUH | - |
crisitem.author.orcid | 0000-0003-1472-1231 | - |
crisitem.author.orcid | 0000-0002-3878-4491 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。